LGOFX | PEMGX | LGOFX / PEMGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 19 years | - |
Gain YTD | 39.038 | 25.517 | 153% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 561M | 29.9B | 2% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 47.63 | 29.83 | 160% |
Returns for 3 years | -14.94 | 6.89 | -217% |
Returns for 5 years | 12.22 | 51.07 | 24% |
Returns for 10 years | 19.41 | 104.51 | 19% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LOGSX | 21.86 | 0.22 | +1.02% |
Live Oak Health Sciences | |||
CEVYX | 12.53 | 0.10 | +0.80% |
Columbia Global Value Inst3 | |||
MLGRX | 9.88 | 0.04 | +0.41% |
NYLI Winslow Large Cap Growth Class R3 | |||
ESISX | 14.52 | -0.01 | -0.07% |
Parametric International Equity R6 | |||
PIEIX | 26.09 | -0.10 | -0.38% |
Principal Glb Emerging Markets Inst |